ADVERTISEMENT
Search

June 2024

Pharmacy Today logo
Volume 30, Issue 6

Archives   Download TOC  

Current Issue

June 2024 cover

Download  

ADVERTISEMENT
 

Practice & Trends

Court upholds student pharmacist dismissal for failed APPE courses

On The Docket

Court upholds student pharmacist dismissal for failed APPE courses

Student pharmacists can be dismissed from their pharmacy program for a variety of reasons, including poor academic performance and academic dishonesty. Most dismissals are relatively easy to support based on objective evidence. The dismissal of a student pharmacist for lack of clinical skills and for unprofessional conduct during APPE courses is more subjective and is more difficult to justify.

David B. Brushwood, BSPharm, JD

Without access to Flovent, the youngest patients face challenges

Pediatric Asthma

Without access to Flovent, the youngest patients face challenges

In January 2024, GSK discontinued sales of its Flovent HFA and Flovent Diskus inhalers. The company attributed the change to the availability of generic alternatives that work just as well but for a potentially lower price. However, few insurance companies cover the authorized generics, leading to serious challenges in finding an acceptable replacement for the drug, particularly for parents of some small children.

Sonya Collins

RSS
Is there a pharmacist shortage?

Association Perspective

Is there a pharmacist shortage?

I recognize that this question will probably result in hot debate. There are those who argue that there isn’t a shortage—rather, there is a lack of pharmacists willing to work in one segment or another.

Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, Executive vice president and CEO of APhA

RSS

Drugs & Diseases

Education key to stopping spread of antimicrobial-resistant ringworm

Infectious Disease

Education key to stopping spread of antimicrobial-resistant ringworm

Antimicrobial-resistant ringworm made headlines last year when a New York City dermatologist notified public health officials of two patients whose ringworm did not improve with oral terbinafine. Since then, stubborn strains of the fungus, which causes itchy, scaly patches of skin, have appeared in at least 11 states, including New York.

Terri D’Arrigo

Exblifep

New Drug

Exblifep

In February 2024, FDA approved Exblifep (cefepime hydrochloride/enmetazobactam—Allecra Therapeutics), a new antibiotic that is indicated for complicated UTIs, including pyelonephritis, in individuals 18 years and older.

Lauren Howell, PharmD

NAD+ supplements

On The Shelf

NAD+ supplements

Recent buzz around a veterinary medicine company developing drugs to extend the lifespan in dogs by targeting the underlying causes of aging has some wondering, if it works for dogs, will it work for humans? The promise of eternal youth has renewed interest in oxidized nicotinamide adenine dinucleotide (NAD+) supplementation.

Mickie Cathers

Spray those allergy symptoms away

OTCs Today

Spray those allergy symptoms away

When allergies cause congestion, itchy and runny nose, sneezing, and watery eyes, most patients reach for antihistamines and decongestants. While both are available as tablets and capsules, nasal sprays are also readily accessible and often work much faster than pills. Several types of nonprescription decongestant, antihistamine, and corticosteroid sprays are convenient and suitable for allergy relief.

Mary Warner

RSS

Health Systems

Trending Topics in Health-System Pharmacy

Inpatient Insights

Trending Topics in Health-System Pharmacy

Despite FDA approval of seven next-generation antibiotics geared toward gram-negative infections between 2014 and 2019, clinicians still frequently treat resistant gram-negative infections with older, generic antibiotics that have suboptimal safety efficacy profiles.

JACC review puts brakes on DOAC use

Anticoagulation

JACC review puts brakes on DOAC use

In January 2024, the Journal of the American College of Cardiology published a systematic review that included a detailed examination of randomized controlled trials exploring the efficacy and safety of direct oral anticoagulants (DOACs) and when they should not be considered standard treatment.

Corey Diamond, PharmD

The jaw-dropping truth about medication-related osteonecrosis of the jaws

Osteonecrosis

The jaw-dropping truth about medication-related osteonecrosis of the jaws

For years, the American Association of Oral and Maxillofacial Surgeons (AAOMS) has been crafting strategies to tackle medication-related osteonecrosis of the jaws (MRONJ), formerly known as bisphosphonate-related osteonecrosis of the jaws. In an update published in the March 2024 issue of the Journal of Oral and Maxillofacial Surgery, experts from AAOMS explain revised diagnosis and management protocols, medication comparisons, and preventive measures aimed at empowering health care providers and enhancing patient care.

Aiya Almogaber, PharmD

RSS

CPE

Medications for weight loss: An update for pharmacists
CPE

CPE

Medications for weight loss: An update for pharmacists

Vital signs, the measurements of the basic functions of our bodies, grant a preliminary picture of our overall health. They include temperature, blood pressure, pulse, and, of ever-increasing concern—weight. Weight issues are exceedingly common for a variety of reasons and can lead to serious health complications.

Christopher R. Piszczatoski, PharmD, BCPS

RSS

In this Issue

ADVERTISEMENT